All news

Cerba Research: collaboration boosts rare-disease discoveries

19-Aug-2020 By Jenni Spinner

A leader from the clinical laboratory and diagnostic solution provider discusses how its research is fueled by partnerships and patient-centricity.

Healx collaborates on Angelman syndrome therapies

19-Aug-2020 By Jenni Spinner

The AI-centric drug discovery technology firm is working with a foundation to discover potential treatments for the rare neurogenetic disorder.

Drug discovery platform aims to accelerate rare-disease therapies

19-Aug-2020 By Jenni Spinner

An online patient community specializing in rare diseases has launched Xperiome, a knowledge platform aimed at speeding development of treatments.

Biorasi: precision medicine trials call for specialized approach

19-Aug-2020 By Jenni Spinner

A leader from the speed-focused CRO talks about the specialized needs of precision medicine trials, and how sites and sponsors can succeed on such studies.

Notable, Washington University join on oncology study

19-Aug-2020 By Jenni Spinner

The precision study at the center of the partnership is geared toward identifying novel synergies across a broad variety of anticancer therapies.

Illingworth: mobile nursing can reduce trial patient burden

18-Aug-2020 By Jenni Spinner

A leader from home-based clinical services firm Illingworth Research Group talks about the evolution of mobile nursing and how it can keep trials going.

BBK Worldwide on navigating patient travel in COVID-19 era

18-Aug-2020 By Jenni Spinner

A leader from the clinical trial patient engagement specialist discusses how clinical trial teams can tackle tricky travel issues in the face of the pandemic.

Ajinomoto grows small-molecule capabilities in India

18-Aug-2020 By Jenni Spinner

The CDMO is expanding its small-molecule manufacturing capacity with a new 8,500-square-meter production facility at its Visakhapatnam, India site.

Novateur study points toward potential COVID-19 treatment

17-Aug-2020 By Jenni Spinner

Researchers at Novateur Ventures have released a strategy that examines leukotrienes as the cause for hyperinflammatory response in severe cases.

Phesi adds country selection to trial site platform

17-Aug-2020 By Jenni Spinner

The company’s AI-powered Clinsite investigator site intelligence platform now offers country selection, designed to help streamline trial efficiency.

Mission Bio raises $70m to help develop cancer therapies

17-Aug-2020 By Jenni Spinner

The company has landed $70m in Series C funding, with the purpose of accelerating development of cancer therapies with single-cell multiomics.

Current FDA COVID-19 news

13-Aug-2020 By Jenni Spinner

The US federal agency continues to keep busy offering resources, issuing EUAs and taking action related to the COVID-19 pandemic.

Reify Health raises $30m for clinical trial tech

13-Aug-2020 By Jenni Spinner

The cloud-based study technology firm has secured Series B funding to help develop and promote products like its clinical trial platform, StudyTeam.

Integrated platform targets trial performance

12-Aug-2020 By Jenni Spinner

A partnership between two trial tech providers aims to create a more powerful, efficient and effective study solution for sites, sponsors and CROs.

Potential HIV cure Phase I trial gets FDA green light

11-Aug-2020 By Jenni Spinner

American Gene Technologies has received the agency’s approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.